RACHEL BREITENSTEIN: Open Payments
NPI 1679018402 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,982 in 220 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,393 · 2025 $3,982
Food & beverage: $3,946Education: $36
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 89 | $1,159 |
| Madrigal Pharmaceuticals | 16 | $489 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $466 |
| Medtronic, Inc. | 9 | $451 |
| Janssen Biotech, Inc. | 25 | $429 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $307 |
| Gilead Sciences, Inc. | 6 | $118 |
| Lilly USA, LLC | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 5 | $80 |
| Ardelyx, Inc. | 3 | $64 |
Products named: REZDIFFRA, INTERSTIM, XIFAXAN, TREMFYA, RINVOQ, ENTYVIO, VIBERZI, MAVYRET.
Industry payments across OH — which companies pay providers there.
